Skip to main content
Premium Trial:

Request an Annual Quote

Interleukin Genetics Moves to New Pink Sheets Service

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Interleukin Genetics has moved its stock from the New York Stock Exchange Amex to the Pink Quote’s OTCQB, a new quotation service run by Pink OTC Markets, as of today.

Stock in the Waltham, Mass.-based genetic testing company, which is now listed under the symbol ILIU.PK, was listed as trading this morning at $.25 a share, down 40 percent from its Friday close.

Interleukin received a delisting notice from the New York Stock Exchange's Amex in June.

The OTCQB was introduced recently to distinguish over-the counter securities that are registered and are reporting with the US Securities and Exchange Commission or a banking or insurance regulator.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.